|
Market Closed -
Nasdaq Stockholm
17:00:00 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 19.84 SEK | +2.69% |
|
-0.50% | -12.21% |
| 08-20 | SynAct Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-20 | Synact Pharma reports narrower operating loss | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYNACT PHARMA AB | Other Pharmaceuticals | +2.69% | -0.50% | -12.21% | +10.59% | -82.06% | 117M |  |  | |
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
